These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8351532)

  • 21. Hepatitis B: Time to Evaluate Universal Screening and Vaccination in Pregnancy?
    Badell ML
    Obstet Gynecol; 2022 Mar; 139(3):355-356. PubMed ID: 35119420
    [No Abstract]   [Full Text] [Related]  

  • 22. An economic assessment of pre-vaccination screening for hepatitis A and B.
    Jacobs RJ; Saab S; Meyerhoff AS; Koff RS
    Public Health Rep; 2003; 118(6):550-8. PubMed ID: 14563912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
    Wright CM; Boudarène L; Ha NT; Wu O; Hawkins N
    BMC Public Health; 2018 Mar; 18(1):373. PubMed ID: 29558894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
    Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
    Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
    Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
    Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of hepatitis B vaccination of prison inmates.
    Pisu M; Meltzer MI; Lyerla R
    Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
    Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes.
    Hoerger TJ; Schillie S; Wittenborn JS; Bradley CL; Zhou F; Byrd K; Murphy TV
    Diabetes Care; 2013 Jan; 36(1):63-9. PubMed ID: 22933435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of economic outcomes of "hepatitis B vaccine event reported by media" in China, 2013].
    Zhang SX; Sun PP; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):837-841. PubMed ID: 30107719
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ; Koff RS; Meyerhoff AS
    Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec.
    Audet AM; Delage G; Remis RS
    Can J Public Health; 1991; 82(3):191-5. PubMed ID: 1909210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.
    Haberland CA; Benitz WE; Sanders GD; Pietzsch JB; Yamada S; Nguyen L; Garber AM
    Pediatrics; 2002 Sep; 110(3):471-80. PubMed ID: 12205247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin.
    Guo Y; Zhang W; Zhang Y; Lin X; Zhang B; Chen C; Du Y
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1363-9. PubMed ID: 22922527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
    Demarteau N; Van Kriekinge G; Simon P
    Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain.
    Antoñanzas F; Garuz R; Rovira J; Antón F; Trinxet C; Navas E; Salleras L
    Pharmacoeconomics; 1995 May; 7(5):428-43. PubMed ID: 10155330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program.
    Krahn M; Guasparini R; Sherman M; Detsky AS
    Am J Public Health; 1998 Nov; 88(11):1638-44. PubMed ID: 9807529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
    Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.